ReviewJRSM cardiovascular disease

Pro-adrenomedullin as a prognostic biomarker in patients with heart failure: A systematic review and meta-analysis.

Zain Albdour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.